Effects of Variable Load Exercise on Aging Atrophy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03690258 |
|
Recruitment Status : Unknown
Verified September 2019 by Damir Zubac, University Hospital of Split.
Recruitment status was: Recruiting
First Posted : October 1, 2018
Last Update Posted : September 26, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
The primary aim of this research proposal is to examine whether this novel training program approach is capable to tackle excessive loss in muscle mass, function and contractile capacity with aging. Previous investigations have universally shown a dramatic loss in type II muscle fibers, while certain countermeasures in their follow-up studies were generally ineffective and limited to attenuate this phenomenon. Probably, they failed to meet recruitment threshold of larger motor units and subsequently innervate type II muscle fibers. Furthermore, previous investigations also failed to provide any data on specific blood markers that may provide additional insight into muscle fiber loss with aging. Muscle fibers type II play a crucial role in the human ability to produce as much as force as possible over a limited time-frame (e.g. 100-200 ms) to counteract unexpected perturbations during stair climbing for example and thus avoiding falls. Therefore, this data collection would be noteworthy in particular, especially for this population due to health-related outcomes and healthy aging process.
Since age-related decline is accelerated already after short bouts of physical inactivity, with small recovery potential, any attempt to counteract age-related and disuse-related decline have high clinical significance. Based on the findings, data collected may aid in development of safety guidelines and protocols aimed at reducing health risks in this specific population. Importantly, in case the aforementioned hypotheses are confirmed, present findings may offer important information to the healthcare system, especially for reducing economic burden.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sarcopenia Hypertension Muscle Atrophy | Device: Variable load exercise | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 30 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Intervention Model Description: | Variable load exercise, non-pharmacological intervention |
| Masking: | Single (Investigator) |
| Masking Description: | Researches collecting data will be blinded of participant allocation. |
| Primary Purpose: | Prevention |
| Official Title: | The Effects of Variable Load Exercise on Muscle Function and Blood Pressure Regulation: a Randomized Controlled Trail |
| Actual Study Start Date : | July 5, 2019 |
| Estimated Primary Completion Date : | March 30, 2020 |
| Estimated Study Completion Date : | July 30, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Variable load exercise
Variable load intervention (The nHANCE-squat ultimate - iso-inertial load, with power output in watts performed 3 x per week) will being performed to determine whether this training approach is an effective countermeasure to attenuate for rapid declines in muscle power, function, contractile capacity that typically originate from aging and muscle disuse. Since age-related decline is accelerated already after short bouts of physical inactivity, with small recovery potential, any attempt to counteract age-related and disuse-related decline have high clinical significance. Based on the findings, we could develop safety guidelines and protocols aimed at reducing health risks in seniors. Data available at: http://nhance.se/ |
Device: Variable load exercise
This study is being conducted to determine whether variable load training approach (nHANCE™ squat - more data available at http://nhance.se/) is an effective countermeasure to attenuate for rapid declines in muscle power, function, that typically originate from aging and muscle disuse. Since age-related decline is accelerated already after short bouts of physical inactivity, with small recovery potential, any attempt to counteract age-related and disuse-related decline have high clinical significance. Based on the findings, safety guidelines and protocols could be developed aimed at reducing health risks in seniors. Importantly, in case present hypotheses are confirmed, this may offer important information to the healthcare system. |
|
Experimental: Variable load intervention
This study is being conducted to determine whether this variable load (The nHANC dead lift - eccentric overload performed 3 x per week for 4-6 weeks) intervention is an effective countermeasure to modulate blood pressure in seniors. Since age-related incline in resting blood pressure (hypertension) is accelerated already after short bouts of physical inactivity, any attempt to counteract age-related and disuse-related decline have high clinical significance. In addition, we aim to examine endothelial function via non-invasive flow mediated dilatation (FMD) technique. Based on the findings, we could develop safety guidelines and protocols aimed at reducing health risks in this specific population. Importantly, in case present hypotheses are confirmed, this may offer important information to the healthcare system, especially for reducing economic burden. |
Device: Variable load exercise
This study is being conducted to determine whether variable load training approach (nHANCE™ squat - more data available at http://nhance.se/) is an effective countermeasure to attenuate for rapid declines in muscle power, function, that typically originate from aging and muscle disuse. Since age-related decline is accelerated already after short bouts of physical inactivity, with small recovery potential, any attempt to counteract age-related and disuse-related decline have high clinical significance. Based on the findings, safety guidelines and protocols could be developed aimed at reducing health risks in seniors. Importantly, in case present hypotheses are confirmed, this may offer important information to the healthcare system. |
- Continuous blood pressure monitoring via photopletismograpy (via Finometer) and non-invasive hemodynamics assessment [ Time Frame: 12-24 months ]Non-pharmacological intervention (exercise intervention); To address motor unit recruitment pattern with pre-post intervention data collection scheme.
- Non invasive surface electromyography (HD EMG, in mV) during MVC (maximal voluntary contraction, Nm), Peak oxygen uptake assessment (VO2; ml kg min-1) [ Time Frame: 12-24 months ]Pulmonary ventilation and oxygen uptake at rest and during cycling. All data will be collected via a portable system (K5 RQ, Cosmed, Rome, Italy)
- Endothelial function (via non invasive flow mediated dilatation technique [ Time Frame: 12-24 months ]During exercise testing we plan to use s it is a portable ultrasound imaging
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 50 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
-
Inclusion criteria:
Both genders will be included;
- signed informed consent and doctor's permission;
- Age >50 years;
- BMI <30 kg/m2,
- At least 30 minutes of daily moderate-to-vigorous physical activity during (including five days of monitoring prior to any data collection).
-
Exclusion criteria:
- Severe cardiovascular diseases;
- hypertension prevalence (>140/90 mm Hg).
- history of severe musculoskeletal and neurological disorders/injuries;
- history of severe neurological disorders;
- supplement or drug consumption that may interfere with training outcomes;
- alcohol consumption and smoking;
- use of walking aids;
The risks and benefits will be outlined to each participant before inclusion into the study.
Data collection risks include potential transient discomfort from the venipuncture blood sampling and muscle soreness originating from experimental training protocols. The participants will get valuable information on how their muscles adapt following systematic training protocols.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03690258
| Contact: Patricia Kompara, Msc | +386 5 663 77 08 | patricia.kompara@zrs-kp.si |
| Slovenia | |
| University of Primorska | Not yet recruiting |
| Koper, Slovenia, 6000 | |
| Contact: University o Primorska | |
| Principal Investigator: Damir Zubac, PhD | |
| Sub-Investigator: Bostjan Simunic, PhD | |
| Sub-Investigator: Vladimir Ivancev, PhD | |
| Sub-Investigator: Armin Paravlic, MSc | |
| Sub-Investigator: Uros Marusic, PhD | |
| Sub-Investigator: Katja Koren, PhD | |
| ZRS Koper | Recruiting |
| Koper, Slovenia, 6000 | |
| Contact: Damir o Zubac, PhD 0955021976 damir.zubac@kifst.hr | |
| Study Director: | Rado Pisot, PhD | Science and Research Center Koper, Institute for Kinesiology Research |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Damir Zubac, PhD, University Hospital of Split |
| ClinicalTrials.gov Identifier: | NCT03690258 |
| Other Study ID Numbers: |
ARRS: Z7-9420 |
| First Posted: | October 1, 2018 Key Record Dates |
| Last Update Posted: | September 26, 2019 |
| Last Verified: | September 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
muscle function; muscle fibers; systolic blood pressure |
|
Sarcopenia Muscular Atrophy Atrophy Pathological Conditions, Anatomical |
Neuromuscular Manifestations Neurologic Manifestations Nervous System Diseases |

